Dialysis in Special Clinical Situations: Anesthesia

  • Bertram L. Kasiske


The number of patients with chronic renal failure who undergo surgery is not likely to decrease in the near future. In the United States, for example, there have been notable demographic trends in the end stage renal disease patient population over the past several years that will ensure a continued need for surgical interventions. Not only has the size of the population grown, but the number and complexity of complications among patients with end stage renal disease has also grown. This is in large part due to the fact that increasingly greater proportions of patients with end stage renal disease are older and have diabetes (1). As a result of these trends, the need for surgery in patients with chronic renal failure is unlikely to diminish any time soon


Chronic Renal Failure Dialysis Patient Narcotic Analgesic Chronic Renal Failure Patient Sodium Polystyrene Sulfonate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    US Renal Data System, USRDS 1993 Annual Data Report, Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive, 1993Google Scholar
  2. 2.
    Collins VJ: Preanesthetic evaluation and preparation, in Principles of Anesthesiology, 3rd Edition, Philadelphia, Lea & Febiger, 1993, p 207Google Scholar
  3. 3.
    Roizen MF: Preoperative evaluation, in Anesthesia, 3rd Edition, edited by Miller RD, New York, Churchill Livingstone, 1990, p 743Google Scholar
  4. 4.
    Gluck R, Munoz E, Wise L: Preoperative and postoperative medical evaluation of surgical patients. Am J Surg 155: 730, 1988PubMedGoogle Scholar
  5. 5.
    Houston MC, Ratcliff DG, Hays JT, Gluck FW: Preoperative medical consultation and evaluation of surgical risk. South Med J 80: 1385, 1987PubMedGoogle Scholar
  6. 6.
    De Meyer M, Wyns W, Dion R, Khoury G, Pirson Y, van Ypersele de Strihou C: Myocardial revascularization in patients on renal replacement therapy. Clin Nephrol 36: 147, 1991PubMedGoogle Scholar
  7. 7.
    Blakeman BM, Pifarre R, Sullivan HJ, Montoya A, Bakhos M: Cardiac surgery for chronic renal dialysis patients. Chest 95: 509, 1989PubMedGoogle Scholar
  8. 8.
    Batiuk TD, Kurtz SB, Oh JK, Orszulak TA: Coronary artery bypass operation in dialysis patients. Mayo Clin Proc 66: 45, 1991PubMedGoogle Scholar
  9. 9.
    Deutsch E, Bernstein RC, Addonizio VP, Kussmaul WG, III: Coronary artery bypass surgery in patients on chronic hemodialysis. Ann Intern Med 110: 369, 1989PubMedGoogle Scholar
  10. 10.
    Opsahl JA, Husebye DG, Helseth HK, Collins AJ: Coronary artery bypass surgery in patients on maintenance dialysis: long-term survival. Am J Kidney Dis 12: 271, 1988PubMedGoogle Scholar
  11. 11.
    Rostand SG, Kirk KA, Rutsky EA, Pacifico AD: Results of coronary artery bypass grafting in end-stage renal disease. Am J Kidney Dis 12: 266, 1988PubMedGoogle Scholar
  12. 12.
    Laws KH, Merrill WH, Hammon JW Jr, Prager RL, Bender HW Jr: Cardiac surgery in patients with chronic renal disease. Ann Thorac Surg 42: 152, 1986PubMedCrossRefGoogle Scholar
  13. 13.
    Marshall WG Jr, Rossi NP, Meng RL, Wedige-Stecher T: Coronary artery bypass grafting in dialysis patients. Ann Thorac Surg 42: S12, 1986CrossRefGoogle Scholar
  14. 14.
    Gersh BJ, Kronmal RA, Schaff HV et al.: Lont-term (5 year) results of coronary bypass surgery in patients 65 years old or older: a report from the Coronary Artery Surgery Study. Circulation 68(Suppl II): 11–190, 1983Google Scholar
  15. 15.
    Hall RJ, Elayda MA, Gray A et al.: Coronary artery bypass: long-term follow-up of 22,284 cohsecutive patients. Circulation 68(Suppl II): 11–20, 1983Google Scholar
  16. 16.
    Haimov M, Glabman S, Schupak E, Neff M, Burrows L: General surgery in patients on maintenance hemodialysis. Ann Surg 179:863, 1974PubMedGoogle Scholar
  17. 17.
    Marsland AR, Bradley JP: Anaesthesia for renal transplantation — 5 years’ experience. Anaesth Intensive Care 11:337, 1983PubMedGoogle Scholar
  18. 18.
    Heino A, Orko R, Rosenberg PH: Anaesthesiological complications in renal transplantation: a retrospective study of 500 transplantations. Acta Anaesthesiol Scand 30: 574, 1986PubMedGoogle Scholar
  19. 19.
    Sheikh F, Khubchandani IT, Rosen L, Sheets JA, Stasik JJ: Is anorectal surgery on chronic dialysis patients risky? Dis Colon Rectum 35: 56, 1992PubMedGoogle Scholar
  20. 20.
    Owens WD, Felts JA, Spitznagel EL Jr: ASA physical status classifications: a study of consistency of ratings. Anesthesiology 49: 239, 1978PubMedGoogle Scholar
  21. 21.
    Cohen MM, Duncan PG, Tate RB: Does anesthesia contribute to operative mortality? JAMA 260: 2859, 1988PubMedGoogle Scholar
  22. 22.
    Vacanti CJ, VanHouten RJ, Hill RC: A statistical analysis of the relationship of physical status to postoperative mortality in 68,388 cases. Anesth Analg 49: 564, 1970PubMedGoogle Scholar
  23. 23.
    Marx GF, Mateo CV, Orkin LR: Computer analysis of postanesthetic deaths. Anesthesiology 39: 54, 1973PubMedGoogle Scholar
  24. 24.
    Greaves SC, Sharpe DN: Cardiovascular disease in patients with end-stage renal failure. Aust N Z J Med 22: 153, 1992PubMedGoogle Scholar
  25. 25.
    Parfrey PS: Cardiac and cerebrovascular disease in chronic uremia. Am J Kidney Dis 21: 77, 1993PubMedGoogle Scholar
  26. 26.
    Goldman L, Caldera DL, Nussbaum SR et al.: Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297: 845, 1977PubMedCrossRefGoogle Scholar
  27. 27.
    Goldman L: Assessment of the patient with known or suspected ischaemic heart disease for non-cardiac surgery. Br J Anaesth 61: 38, 1988PubMedGoogle Scholar
  28. 28.
    Goldman L: Multifactorial index of cardiac risk in non-cardiac surgery: ten-year status report. J Cardiothorac Anesth 1:237–244, 1987PubMedGoogle Scholar
  29. 29.
    Jeffrey CC, Kunsman J, Cullen DJ, Brewster DC: A prospective evaluation of cardiac risk index. Anesthesiology 58: 462, 1983PubMedGoogle Scholar
  30. 30.
    Carliner NH, Fisher ML, Plotnick GD et al.: Routine preoperative exercise testing in patients undergoing major noncardiac surgery. Am J Cardiol 56: 51, 1985PubMedGoogle Scholar
  31. 31.
    Gerson MC, Hurst JM, Hertzberg VS et al.: Cardiac prognosis in noncardiac geriatric surgery. Ann Intern Med 103: 832, 1985PubMedGoogle Scholar
  32. 32.
    Meguid MM, Mughal MM, Meguid V, Tent JJ: Riskbenefit analysis of malnutrition and perioperative nutritional support: a review. Nutrition International 3: 25, 1987Google Scholar
  33. 33.
    Hensle TW, Askanazi J: Metabolism and nutrition in the perioperative period. J Urol 139: 229, 1988PubMedGoogle Scholar
  34. 34.
    Lowrie EG, Lew NL: Commonly measured laboratory variables in hemodialysis patients: relationships among them and to death risk. Semin Nephrol 12: 276, 1992PubMedGoogle Scholar
  35. 35.
    Charlson ME, MacKenzie CR, Gold JP, Ales KL, Topkins M, Shires GT: Preoperative characteristics predicting intraoperative hypotension and hypertension among hypertensives and diabetics undergoing noncardiac surgery. Ann Surg 212: 66, 1990PubMedGoogle Scholar
  36. 36.
    Goldman L, Caldera DL. Risks of general anesthesia and elective operation in the hypertensive patient. Anesthesiology 50: 285, 1979PubMedGoogle Scholar
  37. 37.
    Pouttu J: Haemodynamic responses during general anaesthesia for renal transplantation in patients with and without hypertensive disease. Acta Anaesthesiol Scand 33: 245, 1989PubMedGoogle Scholar
  38. 38.
    Livio M, Mannucci PM, Vigano G et al.: Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 315: 731, 1986PubMedCrossRefGoogle Scholar
  39. 39.
    Vigano G, Gaspari F, Locatelli M, Pusineri F, Bonati M, Remuzzi G: Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremia. Kidney Int 34: 853, 1988PubMedGoogle Scholar
  40. 40.
    Shemin D, Elnour M, Amarantes B, Abuelo JG, Chazan JA: Oral estrogens decrease bleeding time and improve clinical bleeding in patients with renal failure. Am J Med 89: 436, 1990PubMedGoogle Scholar
  41. 41.
    Janson PA, Jubelirer SJ, Weinstein MJ, Deykin D: Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 303: 1318, 1980PubMedCrossRefGoogle Scholar
  42. 42.
    Mannucci PM, Remuzzi G, Pusineri F et al.: Deamino8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308: 8, 1983PubMedCrossRefGoogle Scholar
  43. 43.
    Bromage PR, Gertel M: Brachial plexus anesthesia in chronic renal failure. Anesthesiology 36: 488, 1972PubMedGoogle Scholar
  44. 44.
    Martin R, Beauregard L, Tétrault JP: Brachial plexus blockade and chronic renal failure. Anesthesiology 69: 405, 1988PubMedGoogle Scholar
  45. 45.
    Rooke NT, Milne B: Acute pulmonary edema after regional anesthesia with lidocaine and epinephrine in a patient with chronic renal failure. Anesth Analg 63: 363, 1984PubMedGoogle Scholar
  46. 46.
    Gould DB, Aldrete JA: Bupivacaine cardiotoxicity in a patient with renal failure. Acta Anaesthesiol Scand 27: 18, 1983PubMedGoogle Scholar
  47. 47.
    Linke CL, Merin RG: A regional anesthetic approach for renal transplantation. Anesth Analg 55: 69, 1976PubMedGoogle Scholar
  48. 48.
    Gosselin RE, Gabourel JD, Wills JH: The fate of atropine in man. Clin Pharmacol Ther 1: 597, 1960.Google Scholar
  49. 49.
    Tønnesen M: The excretion of atropine and allied alkaloids in urine. Acta Pharmacol Toxicol 6: 147, 1950.CrossRefGoogle Scholar
  50. 50.
    Verbeeck RK, Branch RA, Wilkinson GR: Meperidine disposition in man: influence of urinary pH and route of administration. Clin Pharmacol Ther 30: 619, 1981PubMedCrossRefGoogle Scholar
  51. 51.
    Olsen GD, Bennett WM, Porter GA: Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther 17: 677, 1975PubMedGoogle Scholar
  52. 52.
    Don HF, Dieppa RA, Taylor P: Narcotic analgesics in anuric patients. Anesthesiology 42: 745, 1975PubMedCrossRefGoogle Scholar
  53. 53.
    Aweeka FT: Drug dosing in renal failure, in Applied Therapeuties — The Clinical Use of Drugs, 5th Edition, edited by Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ, Vancouver, Applied Therapeutics, Inc, 1992, p 26–31Google Scholar
  54. 54.
    Hug CC Jr, Murphy MR: Tissue redistribution of fentanyl and termination of its effects in rats. Anesthesiologv 55: 369, 1981Google Scholar
  55. 55.
    McClain DA, Hug CC Jr: Intravenous fentanyl kinetics. Clin Pharmacol Ther 28: 106, 1980PubMedCrossRefGoogle Scholar
  56. 56.
    Mather LE: Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 8: 422, 1983PubMedGoogle Scholar
  57. 57.
    Bower S: Plasma protein binding of fentanyl: the effect of hyperlipoproteinaemia and chronic renal failure. J Pharm Pharmacol 34: 102, 1982PubMedGoogle Scholar
  58. 58.
    Sear JW: Sufentanil disposition in patients undergoing renal transplantation: influence of choice of kinetic model. Br J Anaesth 63: 60, 1989PubMedGoogle Scholar
  59. 59.
    Fyman PN, Reynolds JR, Moser F, Avitable M, Casthely PA, Butt K: Pharmacokinetics of sufentanil in patients undergoing renal transplantation (see comments). Can J Anaesth 35: 312, 1988PubMedGoogle Scholar
  60. 60.
    Davis PJ, Stiller RL, Cook DR, Brandom BW, Davin-Robinson KA: Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure. Anesth Analg 67: 268, 1988PubMedGoogle Scholar
  61. 61.
    Chauvin M, Lebrault C, Levron JC, Duvaldestin P: Pharmacokinetics of alfentanil in chronic renal failure. Anesth Analg 66: 53, 1987PubMedGoogle Scholar
  62. 62.
    Van Peer A, Vercauteren M, Noorduin H, Woestenborghs R, Heykants J: Alfentanil kinetics in renal insufficiency. EurJ Clin Pharmacol 30: 245, 1986Google Scholar
  63. 63.
    Wiggum DC, Cork RC, Weldon ST, Gandolfi AJ, Perry DS: Postoperative respiratory depression and elevated sufentanil levels in a patient with chronic renal failure. Anesthesiology 63: 708, 1985PubMedGoogle Scholar
  64. 64.
    Lindahl-Nilsson C, Lundh R, Groth CG: Neurolept anaesthesia for the renal transplant operation. Acta Anaesthesiol Scand 24: 451, 1980PubMedCrossRefGoogle Scholar
  65. 65.
    Dundee JW, Richards RK: Effect of azotemia upon the action of intravenous barbiturate anesthesia. Anesthesiology 15: 333, 1954.PubMedGoogle Scholar
  66. 66.
    Ghoneim MM, Pandya HB, Kelley SE, Fischer LJ, Corry RJ: Binding of thiopental to plasma proteins: effects on distribution in the brain and heart. Anesthesiology 45: 635, 1976PubMedGoogle Scholar
  67. 67.
    Ghoneim MM, Pandya H: Plasma protein binding of thiopental in patients with impaired renal or hepatic function. Anesthesiology 42: 545, 1975PubMedGoogle Scholar
  68. 68.
    Burch PG, Stanski DR: Decreased protein binding and thiopental kinetics. Clin Pharmacol Ther 32: 212, 1982PubMedCrossRefGoogle Scholar
  69. 69.
    Vinik HR, Reves JG, Greenblatt DJ, Abernethy DR, Smith LR: The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology 59: 390, 1983PubMedGoogle Scholar
  70. 70.
    Ochs HR, Rauh HW, Greenblatt DJ, Kaschell HJ: Clorazepate dipotassium and diazepam in renal insufficiency: serum concentrations and protein binding of diazepam and desmethyldiazepam. Nephron 37: 100, 1984PubMedGoogle Scholar
  71. 71.
    Collins AJ, Ma JZ, Urnen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 23: 272, 1994PubMedGoogle Scholar
  72. 72.
    Mazze RI, Cousins MJ, Barr GA: Renal effects and metabolism of isoflurane in man. Anesthesiology 40: 536, 1974PubMedGoogle Scholar
  73. 73.
    Mazze RI: Metabolism of the inhaled anaesthetics: implications of enzyme induction. Br J Anaesth 56: 27S, 1984Google Scholar
  74. 74.
    Wickström I: Enflurane anesthesia in living donor renal transplantation. Acta Anaesthesiol Scand 25: 263, 1981PubMedGoogle Scholar
  75. 75.
    Cousins MJ, Mazze RI: Methoxyflurane nephrotoxicity — a study of dose response in man. JAMA 225: 1611, 1973PubMedGoogle Scholar
  76. 76.
    Mazze RI, Sievenpiper TS, Stevenson J: Renal effects of enflurane and halothane in patients with abnormal renal function. Anesthesiology 60: 161, 1984PubMedGoogle Scholar
  77. 77.
    Desmond JW, Gordon RA: The effect of haemodialysis on blood volume and plasma cholinesterase levels. Can J Anaesth 16:292, 1969.Google Scholar
  78. 78.
    Ryan DW: Preoperative serum cholinesterase concentration in chronic renal failure. Br J Anaesth 49: 945, 1977PubMedGoogle Scholar
  79. 79.
    Thomas JL, Holmes JH: Effect of hemodialysis on plasma cholinesterase. Anesth Analg 49: 323, 1970.PubMedGoogle Scholar
  80. 80.
    Sirotzky L, Lewis EJ: Anesthesia related muscle paralysis in renal failure. Clin Nephrol 10: 38, 1978PubMedGoogle Scholar
  81. 81.
    Gronert GA, Theye RA: Pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology 43: 89, 1975PubMedGoogle Scholar
  82. 82.
    Koide M, Waud BE: Serum potassium concentrations after succinylcholine in patients with renal failure. Anesthesiology 36: 142, 1972PubMedGoogle Scholar
  83. 83.
    Miller RD, Way WL, Hamilton WK, Layzer RB: Succinylcholine-induced hyperkalemia in patients with renal failure? Anesthesiology 36: 138, 1972PubMedGoogle Scholar
  84. 84.
    Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J: Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 25: 358, 1979PubMedGoogle Scholar
  85. 85.
    Miller RD, Matteo RS, Benet LZ, Sohn YJ: The pharmacokinetics of d-tubocurarine in man with and without renal failure. J Pharmacol Exp Ther 202: 1, 1977PubMedGoogle Scholar
  86. 86.
    Matteo RS, Nishitateno K, Pua EK, Spector S: Pharmacokinetics of d-tubocurarine in man: effect of an osmotic diuretic on urinary excretion. Anesthesiology 52: 335, 1980PubMedGoogle Scholar
  87. 87.
    Gibaldi M, Levy G, Hayton WL: Tubocurarine and renal failure. Br J Anaesth 44: 163, 1972PubMedGoogle Scholar
  88. 88.
    Somogyi AA, Shanks CA, Triggs EJ: The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide. Eur J Clin Pharmacol 12:23, 1977PubMedGoogle Scholar
  89. 89.
    McLeod K, Watson MJ, Rawlins MD: Pharmacokinetics of pancuronium in patients with normal and impaired renal function. Br J Anaesth 48: 341, 1976PubMedGoogle Scholar
  90. 90.
    Brotherton WP, Matteo RS: Pharmacokinetics and pharmacodyanmics of metocurine in humans with and without renal failure. Anesthesiology 55: 273, 1981PubMedGoogle Scholar
  91. 91.
    Ramzan MI, Shanks CA, Triggs EJ: Gallamine disposition in surgical patients with chronic renal failure. Br J Clin Pharmacol 12: 141, 1981PubMedGoogle Scholar
  92. 92.
    Feldman SA, Levi JA: Prolonged paresis following gallamine: A case report. Br J Anaesth 35: 804, 1963.PubMedGoogle Scholar
  93. 93.
    Fahey MR, Rupp SM, Fisher DM et al.: The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology 61: 699, 1984PubMedGoogle Scholar
  94. 94.
    Orko R, Heino A, Björkstén F, Scheinin B, Rosenberg PH: Comparison of atracurium and vecuronium in anaesthesia for renal transplantation. Acta Anaesthesiol Scand 31: 450, 1987PubMedCrossRefGoogle Scholar
  95. 95.
    Link J, Papadopoulos G, Heine P. Wolter J: The action of atracurium and vecuronium in chronically hemodialyzed patients. Anaesthesist 42: 34, 1993PubMedGoogle Scholar
  96. 96.
    Bach A, Layer M: Muscle relaxants for kidney transplantation. A comparison between vecuronium and atracurium. Anaesthesist 39: 96, 1990PubMedGoogle Scholar
  97. 97.
    Lepage JY, Malinge M, Cozian A, Pinaud M, Blanloeil Y, Souron R: Vecuronium and atracurium in patients with end-stage renal failure. A comparative study. Br J Anaesth 59: 1004, 1987PubMedGoogle Scholar
  98. 98.
    Gramstad L: Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine. Br J Anaesth 59: 995, 1987PubMedGoogle Scholar
  99. 99.
    Lynam DP, Cronnelly R, Castagnoli KP et al.: The pharmacodynamics and pharmacokinetics of vecuronium in patients anesthetized with isoflurane with normal renal function or with renal failure. Anesthesiology 69: 227, 1988PubMedGoogle Scholar
  100. 100.
    Beauvoir C, Peray P, Daures JP, Peschaud JL, D’Athis F: Pharmacodynamics of vecuronium in patients with and without renal failure: a meta-analysis. Can J Anaesth 40: 696, 1993PubMedGoogle Scholar
  101. 101.
    Takita K, Goda Y, Kawahigashi H, Okuyama A, Kubota M, Kemmotsu O: Pharmacodynamics of vecuronium in the kidney transplant recipient and the patient wish normal renal function. Masui 42: 190, 1993PubMedGoogle Scholar
  102. 102.
    Lagasse RS, Katz RI, Petersen M, Jacobson MJ, Poppers PJ: Prolonged neuromuscular blockade following vecuronium infusion. J Clin Anesth 2: 269, 1990PubMedGoogle Scholar
  103. 103.
    Vanacker BF, Van de Walle J: The neuromuscular blocking action of vecuronium in normal patients and in patients with no renal function and interaction vecuronium-tobramycin in renal transplant patients. Acta Anaesthesiol Belg 37: 95, 1986PubMedGoogle Scholar
  104. 104.
    Cashman JN, Luke JJ, Jones RM: Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function. Br J Anaesth 64: 186, 1990PubMedGoogle Scholar
  105. 105.
    Khuenl-Brady KS, Pomaroli A, Puhringer F, Mitterschiffthaler G, Koller J: The use of rocuronium (ORG 9426) in patients with chronic renal failure. Anaesthesia 48: 873, 1993PubMedGoogle Scholar
  106. 106.
    Szenohradszky J, Fisher DM, Segredo V et a1.: Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiology 77: 899, 1992PubMedGoogle Scholar
  107. 107.
    Cook DR, Freeman JA, Lai AA et al.: Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. BrJ Anaesth 69: 580, 1992Google Scholar
  108. 108.
    Sidi A, Kaplan RF, Davis RF: Prolonged neuromuscular blockade and ventilatory failure after renal transplantation and cyclosporine (see comments). Can J Anaesth 37: 543, 1990PubMedGoogle Scholar
  109. 109.
    Crosby E, Robblee JA: Cyclosporine-pancuronium interaction in a patient with a renal allograft. Can J Anaesth 35: 300, 1988PubMedCrossRefGoogle Scholar
  110. 110.
    Gramstad L, Gjerløw JA, Hysing ES, Rugstad HE: Interaction of cyclosporin and its solvent, cremophor, with atracurium and vecuronium. Br J Anaesth 58: 1149, 1986PubMedGoogle Scholar
  111. 111.
    Morris RB, Cronnelly R, Miller RD, Stanski DR, Fahey MR: Pharmacokinetics of edrophonium in anephric and renal transplant patients. Br J Anaesth 53: 131, 1981Google Scholar
  112. 112.
    Cronnelly R, Stanski DR, Miller RD, Sheiner LB, Sohn YJ: Renal function and the pharmacokinetics of neostigmine in anesthetized man. Anesthesiology 51: 222, 1979PubMedGoogle Scholar
  113. 113.
    Cronnelly R, Stanski DR, Miller RD, Sheiner LB: Pyridostigmine kinetics with and without renal function. Clin Pharmacol Ther 28: 78, 1980PubMedCrossRefGoogle Scholar
  114. 114.
    Aquilonius SM, Hartvig P: Clinical pharmacokinetics of cholinesterase inhibitors. Clin Pharmacokinet 11: 236, 1986PubMedCrossRefGoogle Scholar
  115. 115.
    Leanza HJ, Rivarola G, Graciela Garcia M, Najun Zarazaga CJ, Casadei D: Rapid correction of acute hyperkalemia with nebulized salbutamol. Medicina 52: 99, 1992PubMedGoogle Scholar
  116. 116.
    Velaszuez L, Munoz R: The treatment of hyperkalemia with salbutamol. Bol Med Hosp Infant Mex 48: 775, 1991Google Scholar
  117. 117.
    Murdoch IA, Dos Anjos R, Haycock BB. Treatment of hyperkalaemia with intravenous salbutamol. Arch Dis Child 66: 527, 1991PubMedGoogle Scholar
  118. 118.
    Allon M, Takeshian A, Shanklin N: Effect of insulin-plusglucose infusion with or without epinephrine on fasting hyperkalemia. Kidney Int 43: 212, 1993PubMedGoogle Scholar
  119. 119.
    Salem MM, Rosa RM, Batlle DC: Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia. Am J Kidney Dis 18: 421, 1991PubMedGoogle Scholar
  120. 120.
    Allon M, Dunlay R, Copkney C: Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 110:426, 1989PubMedGoogle Scholar
  121. 121.
    Sheinfeld J, Linke CL, Talley TE, Linke CA: Selective pre-transplant nephrectomy: indications and perioperative management. J Urol 133: 379, 1985PubMedGoogle Scholar
  122. 122.
    Ruegg PC, Karmann U, Keller H: Management of perioperative hypertension using intravenous isradipine. Am J Hypertens 4: 203S, 1991Google Scholar
  123. 123.
    Hogenson KD: Acute postoperative hypertension in the hypertensive patient. J Post Anesth Nurs 7: 38, 1992PubMedGoogle Scholar
  124. 124.
    Chrysostomou A, Walker RG, Russ GR, d’Apice AJF, Kincaid-Smith P, Mathew TH: Diltiazem in renal allograft recipients receiving cyclosporine. Transplantation 55: 300, 1993PubMedGoogle Scholar
  125. 125.
    Neumayer H-H, Kunzendorf U, Schreiber M: Protective effects of calcium antagonists in human renal transplantation. Kidney Int 41(Suppl 36): S-87, 1992Google Scholar
  126. 126.
    Harper SJ, Moorhouse J, Veitch PS et al.: Improved immediate graft function with nifedipine in cyclosporinetreated renal allograft recipients — a randomized prospective study. Transplantation 54: 742, 1992PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Bertram L. Kasiske
    • 1
  1. 1.Div. of NephrologyHennepin County Medical CenterMinneapolisUSA

Personalised recommendations